WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve ...
People without a history of stroke or Parkinson's disease and who are between 18 and 35 years old are needed to participate in a motion analysis study at the Kennedy Krieger Institute. Participation ...